Contribution of non-reference alleles in mtDNA of Alzheimer's disease patients

Annals of Clinical and Translational Neurology

Volumn 1, Issue 4, 2014, Pages 284-289

  Casoli, Tiziana ^a   Di Stefano, Giuseppina ^a   Spazzafumo, Liana ^a   Balietti, Marta ^a   Giorgetti, Belinda ^a   Giuli, Cinzia ^b   Postacchini, Demetrio ^b   Fattoretti, Patrizia ^a   Conti, Fiorenzo ^a,c  

^a INRCA   (Italy)

^b Unit of Geriatrics INRCA IRCCS Hospital   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; RNA 16S;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CLINICAL ARTICLE; CLUSTER ANALYSIS; CYTOCHROME OXIDASE SUBUNIT I GENE; D LOOP GENE; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; FEMALE; FLUORESCENCE; GENE; GENE MUTATION; HETEROPLASMY; HUMAN; MALE; ND2 GENE; ND4 GENE; ND5 GENE; NEUROIMAGING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 84938559181     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.42     Document Type: Article

References (21)

1. Smigrodzki RM, Khan SM. Mitochondrial microheteroplasmy and a theory of aging and age-related disease. Rejuvenation Res 2005;8:172–198.
2. Coskun P, Wyrembak J, Schriner SE, et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta 2012;1820:553–564.
3. Payne BA, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 2013;22:384–390.
4. Hudson G, Sims R, Harold D, et al. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 2012;78:1038–1042.
5. Lakatos A, Derbeneva O, Younes D, et al. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging 2010;31:1355–1363.
6. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004;101:10726–10731.
7. Lin MT, Simon DK, Ahn CH, et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 2002;11:133–145.
8. Maitra A, Cohen Y, Gillespie SE, et al. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 2004;14:812–819.
9. Xie HM, Perin JC, Schurr TG, et al. Mitochondrial genome sequence analysis: a custom bioinformatics pipeline substantially improves Affymetrix MitoChip v2.0 call rate and accuracy. BMC Bioinformatics 2011;12:402.
10. Coon KD, Valla J, Szelinger S, et al. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 2006;6:194–210.
11. Storey JD. A direct approach to false discovery rate. J R Stat Soc Series B 2002;64:479–498.
12. Tollervey JR, Wang Z, Hortobágyi T, et al. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res 2011;21:1572–1582.
13. Van Eijsden RG, Gerards M, Eijssen LM, et al. Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients. Genet Med 2006;8:620–627.
14. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207–210.
15. Coskun PE, Wyrembak J, Derbereva O, et al. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimers Dis 2010;20(Suppl. 2):S293–S310.
16. Khan SM, Cassarino DS, Abramova NN, et al. Alzheimer's disease cybrids replicate ß-amyloid abnormalities through cell death pathways. Ann Neurol 2000;48:148–155.
17. Onyango I, Khan S, Miller B, Swerdlow R, et al. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. J Alzheimers Dis 2006;9:183–193.
18. Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012;13:878–890.
19. Sharpley MS, Marciniak C, Eckel-Mahan K, et al. Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition. Cell 2012;151:333–343.
20. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–767.
21. Praticò D, Uryu K, Leight S, et al. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21:4183–4187.